Literature DB >> 9422989

Abl expression in human fetal and adult tissues, tumours, and tumour microvessels.

A J O'Neill1, T G Cotter, J M Russell, E F Gaffney.   

Abstract

Abl kinases encoded by the abl oncogenes inhibit apoptosis without affecting cell proliferation. The aim of this study was to examine a wide range of normal fetal and adult human tissues and a variety of tumour types for Abl immunoreactivity. Sections from 193 paraffin blocks of normal fetal and adult tissues and 72 blocks from representative tumours were stained immunohistochemically using a polyclonal antibody to c-Abl/Bcr-Abl oncoprotein. Weak Abl immunoreactivity was observed in many adult tissues. Moderately intense or strong staining (cytoplasmic, nuclear or membranous) was consistently seen in hyaline cartilage, adipocytes, and ciliated epithelium. In fetal tissues, there was a broadly similar staining pattern, but Abl expression was also seen in muscle (all types) and occasionally in endothelial cells. The most intense staining was seen in sites of endochondral ossification and in the umbilical cord stroma. Negatively staining tissues included epidermis and squamous mucosa, lymph nodes, tonsil, spleen, hepatocytes, and adrenals. Most tumours showed focal or weak Abl immunoreactivity. The most intense staining was seen in chondrosarcoma, liposarcoma, and diffuse gastric (signet ring) adenocarcinoma. In the latter two tumour types, Abl expression was also observed in tumour microvessels. These results suggest that Abl not only functions as an apoptosis inhibitor, but also may have a role in connective tissue maturation and differentiation and in tumour growth and angiogenesis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9422989     DOI: 10.1002/(SICI)1096-9896(199711)183:3<325::AID-PATH941>3.0.CO;2-A

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  12 in total

1.  c-Abl tyrosine kinase promotes adipocyte differentiation by targeting PPAR-gamma 2.

Authors:  Rom Keshet; Zina Bryansker Kraitshtein; Matan Shanzer; Julia Adler; Nina Reuven; Yosef Shaul
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-03       Impact factor: 11.205

2.  c-Abl promotes osteoblast expansion by differentially regulating canonical and non-canonical BMP pathways and p16INK4a expression.

Authors:  Hui-Yi Kua; Huijuan Liu; Wai Fook Leong; Lili Li; Deyong Jia; Gang Ma; Yuanyu Hu; Xueying Wang; Jenny F L Chau; Ye-Guang Chen; Yuji Mishina; Sharon Boast; James Yeh; Li Xia; Guo-Qiang Chen; Lin He; Stephen P Goff; Baojie Li
Journal:  Nat Cell Biol       Date:  2012-06-24       Impact factor: 28.824

3.  Apoptosis in cancer: archaeology, functional relevance and exploitation in novel treatment strategies.

Authors:  E F Gaffney
Journal:  Ir J Med Sci       Date:  2004 Jan-Mar       Impact factor: 1.568

4.  Distinct angiogenic mediators are required for basic fibroblast growth factor- and vascular endothelial growth factor-induced angiogenesis: the role of cytoplasmic tyrosine kinase c-Abl in tumor angiogenesis.

Authors:  Wei Yan; Brooke Bentley; Rong Shao
Journal:  Mol Biol Cell       Date:  2008-03-19       Impact factor: 4.138

5.  The Abelson tyrosine kinase (c-Abl) expression on the mouse uterus and placenta during gestational period.

Authors:  Aylin Yaba; Umit Ali Kayisli; Joshua Johnson; Ramazan Demir; Necdet Demir
Journal:  J Mol Histol       Date:  2011-01-20       Impact factor: 2.611

6.  Abl expression, tumour grade, and apoptosis in chondrosarcoma.

Authors:  M O'Donovan; J M Russell; J J O'Leary; J A Gillan; M P Lawler; E F Gaffney
Journal:  Mol Pathol       Date:  1999-12

7.  The Src family kinase Fyn mediates hyperosmolarity-induced Mrp2 and Bsep retrieval from canalicular membrane.

Authors:  Miriam Cantore; Roland Reinehr; Annika Sommerfeld; Martin Becker; Dieter Häussinger
Journal:  J Biol Chem       Date:  2011-11-04       Impact factor: 5.157

8.  Activation of abl family kinases in solid tumors.

Authors:  Sourik S Ganguly; Rina Plattner
Journal:  Genes Cancer       Date:  2012-05

9.  (124)I-iodopyridopyrimidinone for PET of Abl kinase-expressing tumors in vivo.

Authors:  Mikhail Doubrovin; Tatiana Kochetkova; Elmer Santos; Darren R Veach; Peter Smith-Jones; Nagavarakishore Pillarsetty; Julius Balatoni; William Bornmann; Juri Gelovani; Steven M Larson
Journal:  J Nucl Med       Date:  2010-01       Impact factor: 10.057

10.  Genetic studies of bone diseases: evidence for involvement of DNA damage response proteins in bone remodeling.

Authors:  Xueying Wang; Baojie Li
Journal:  Int J Biomed Sci       Date:  2007-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.